Innovative Approaches in Biopharmaceutical Research: Ensuring Patient-Centric Healthcare Solutions
This webinar highlights the impactful collaboration between Galapagos and MSU, focusing on our shared dedication to patient-centric healthcare. Our partnership has been vital in several initiatives, including the collection of patient voices for our ongoing Phase 2 clinical trial.
At Galapagos, our research in inflammation and oncology is driven by a commitment to ensure that patient perspectives are central to our initiatives, shaping solutions that truly meet patient needs and expectations. A significant aspect of our approach is the development of patient facing materials including informed consent documents.
Zoltan Koleszar, GLPG Patient Advocacy Leader, will share his expertise on how patient recommendations are integrated into these critical documents. He will discuss how we ensure that the informed consent process is transparent, comprehensible, and respectful of patient needs, and outline how these documents are approved for use in clinical trials.
Additionally, this features a pre-recorded segment by Ann Fieuw, GLPG Senior Medical Director. Ann will provide valuable insights into recent trends in dermatomyositis and information on our ongoing clinical trial.
Join us for this comprehensive session to understand how Galapagos is integrating patient feedback into every stage of research, ensuring that our healthcare solutions are as effective and relevant as possible.
